News on diagnostic systems for drugs of abuse and toxicology.
Quidel's CEO said that the strategic acquisition adds an extensive cardiovascular and toxicology POC offering to the firm's medical diagnostics portfolio.
Prescient said the acquisition will expand its lab capabilities and enhance its relationships with local, regional, and national health insurers.
The accreditation covers postmortem and human performance toxicology analysis, including driving under the influence of drugs and alcohol testing.
Abbott said that a lawsuit it filed Thursday tries to obtain important information from Alere before its acquisition is completed.
The firm's confirmation that it is on track with current and Q3 financial report timing may not be enough to appease would-be acquirer Abbott.